John Bradshaw

GlySure Ltd. engages in the development of glucose monitoring devices. It provides prototypes for human clinical testing. The company was founded by Barry Colin Crane in 2003 and is headquartered in Abingdon, the United Kingdom.

Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom.

PneumaCare Ltd. engages in the provision of respiratory diagnostic and monitoring equipment with novel the dimensional imaging technology. Its products include Thora3Di, Thora3Di Compact, Thora3Di Pediatric, and Thora3Di Remote. The company was founded by Richard Iles in 2009 and is headquartered in Ely, the United Kingdom.

Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom.

Eight19 Ltd. is a holding company, which engages in the manufacture of solar cells. Its products include indoor OPV modules, outdoor OPV modules and demonstrators and electronics. The company was founded in 2010 and is headquartered in Cambridge, the United Kingdom.

TopiVert Ltd. develops topical treatments for inflammatory diseases of the eye and gut. Its application is used in the treatment of asthma, chronic obstructive pulmonary disease, and cystic fibrosis and other inflammatory diseases of the lungs. The company was founded by Eric Charles Meldrum in 2011 and is headquartered in London, the United Kingdom.

Creo Medical Ltd. develops, manufactures and commercializes medical device technologies. It offers CROMA system, an electrosurgical unit that delivers bipolar radiofrequency power for the purpose of cutting, and microwave power for the purpose of coagulating tissue to staunch bleeding vessels. The firm also offers RS2 instrument, a retractable injection needle for tissue lift and irrigation. The company was founded by Christopher Paul Hancock and Steven Morris in 2003 and is headquartered in Chepstow, the United Kingdom.

Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom.

Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom.

Autifony SRL is an Italian biotechnology company that develops new medicines. The private company is based in Verona, Italy.

Bradshaw Daniel Ltd. provides Finance Director and CFO Services for Start Ups, SMEs and Growing Businesses. The British company's team of experienced management accounting professionals works tirelessly to help their clients achieve success.

Syncona Investment Management Ltd. (Syncona) is the asset management subsidiary of Syncona Ltd. in Great Britain. Headquartered in London, the firm was co-founded by Martin Murphy alongside The Wellcome Trust. Syncona is focused on founding, building and funding a portfolio of global leaders in life science.

Part of Syncona Ltd., Syncona Discovery Ltd. is a British company that provides investment services. The private company is based in London, UK. Syncona Discovery was founded in 2013.

Science Creates Ventures LLP (Science Creates Ventures) is a venture capital firm founded in 2020 by Harry Destecroix and Jonathan Craton. The firm is headquartered in Bristol, United Kingdom.